Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Lombok Medical Journal
Khusnurrokhman, Gemilang
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Mechanical Engineering Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Pulmonary Tuberculosis with Pneumonia, Pneumoconiosis, and Drug Induced Liver Injury (DILI) Suryantini, Ni Kadek Mega; Khusnurrokhman, Gemilang; Salim Said Thalib; Suryani Padua Fatrullah
Lombok Medical Journal Vol. 4 No. 2 (2025): Lombok Medical Journal Volume 4 Nomor 2
Publisher : Faculty of Medicine, Universitas Mataram

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/lmj.v4i2.5564

Abstract

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. According to the World Health Organization (WHO), TB is one of the top 10 causes of death in the world. TB is divided into pulmonary TB and extrapulmonary TB. Extra-pulmonary TB is defined as TB involving organs other than the lungs (pleura, lymph nodes, abdomen, skin, joints, bones, and other organs). There were 10.4 million cases of TB globally in 2017, and it is estimated that there will be 845.000 new cases of pulmonary TB in Indonesia in 2019. In 2018 approximately seven million new and relapsed TB cases were reported worldwide. The death rate due to TB may reach 1.5 million cases. TB patients can develop several complications before, during or after treatment, including coughing up blood, pneumothorax, respiratory failure, and heart failure. TB patients may have several comorbidities, including pneumonia, pneumoconiosis, and drug induced liver injury (DILI).
Pulmonary Tuberculosis with Pneumonia, Pneumoconiosis, and Drug Induced Liver Injury (DILI) Suryantini, Ni Kadek Mega; Khusnurrokhman, Gemilang; Salim Said Thalib; Suryani Padua Fatrullah
Lombok Medical Journal Vol. 4 No. 2 (2025): Lombok Medical Journal Volume 4 Nomor 2
Publisher : Faculty of Medicine, Universitas Mataram

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/lmj.v4i2.5564

Abstract

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. According to the World Health Organization (WHO), TB is one of the top 10 causes of death in the world. TB is divided into pulmonary TB and extrapulmonary TB. Extra-pulmonary TB is defined as TB involving organs other than the lungs (pleura, lymph nodes, abdomen, skin, joints, bones, and other organs). There were 10.4 million cases of TB globally in 2017, and it is estimated that there will be 845.000 new cases of pulmonary TB in Indonesia in 2019. In 2018 approximately seven million new and relapsed TB cases were reported worldwide. The death rate due to TB may reach 1.5 million cases. TB patients can develop several complications before, during or after treatment, including coughing up blood, pneumothorax, respiratory failure, and heart failure. TB patients may have several comorbidities, including pneumonia, pneumoconiosis, and drug induced liver injury (DILI).
Co-Authors Salim Said Thalib Suryani Padua Fatrullah Suryantini, Ni Kadek Mega